COVID-19 Outpatient Therapeutics - Part 1

February 17, 2022

A panel of frontline experts in dealing with the outpatient treatment of COVID-19 will give discuss unique models on administering outpatient, non oral treatments. The data will be presented to support the EUA for these medications helping with the dilemma of selecting among the different outpatient treatments available. Difference patient characteristics and outcomes will be presented. We will describe the impact of Omicron on the use of monoclonal antibodies for treatment and for prophylaxis.

Target Audience

  • Pharmacists
  • Pharmacy technicians

Learning Objectives

Pharmacist learning objectives

  1. Describe the data submitted to support the EUA submissions for molnupiravir, Paxlovid, and fluvoxamine
  2. Characterize how to select among different outpatient COVID-19 treatment options based on patient characteristics
  3. List operational considerations for dispensing molnupiravir and Paxlovid

Pharmacy technician learning objectives

  1. Recall outpatient COVID-19 treatment options based on patient characteristics

Additional Information

AttachmentSize
PDF icon Helpful Tips for Users - Vizient CE System.pdf134.81 KB
File Information for CE Credit - COVID-19 Outpatient Therapeutics - Part 1.docx125.56 KB
Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CE – Attendance
Course opens: 
02/17/2022
Course expires: 
04/03/2022
Event starts: 
02/17/2022 - 2:00pm CST
Event ends: 
02/17/2022 - 3:00pm CST
Add to calendar: 
Live via webinar
United States
Relevant financial relationships: Natasha Pettit has received consultant/advisor honorarium from Eli Lilly.
Ashley Marx will discuss off-label and investigative use of drugs.
Pratish Patel will discuss off-label use of drugs.
 
Planning committee members
 
Jackie Stokes, BS
Manager, Pharmacy Program
Vizient, Inc.
 
Gretchen Brummel, PharmD, BCPS
Consulting Solutions Director
Vizient, Inc.
 
Course reviewer
 
Gretchen Brummel, PharmD, BCPS
Consulting Solutions Director
Vizient, Inc.
 
Presenters
 
Ashley Marx, PharmD, BCPS, BCIDP
Clinical Pharmacy Specialist, Infectious Diseases
Associate Professor of Clinical Education
UNC Medical Center
UNC Eshelman School of Pharmacy
 
Natasha N. Pettit, PharmD, BCIDP, BCPS
Pharmacy Director Antimicrobial Stewardship
University of Chicago Medical Center
 
Pratish C. Patel, PharmD, BCIDP, AAHIVP
Pharmacy Program Director
Vanderbilt University Medical Center
Joint Accreditation Statement:
 
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
____________________________________________
 
Designation Statement:
 
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-0000-22-107-L01-P
Universal Activity Number: JA0006103-0000-22-107-L01-T
 
CEU
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CE – Attendance
Please login or register to take this course.